Rheumatologic Adverse Events and Cancer Immunotherapy

Clinical trial NCT04791150 · UNKNOWN

Trial details

NCT number: NCT04791150
Sponsor: Poitiers University Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Oncology Autoimmunity Arthritis Adverse Drug Event

Start date: 2021-05-07
Primary completion: 2022-07-07
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.